<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04344990</url>
  </required_header>
  <id_info>
    <org_study_id>10037/23.5.2016</org_study_id>
    <nct_id>NCT04344990</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Management After Total Knee Arthroplasty</brief_title>
  <official_title>Comparison Study of Three Different Methods of Postoperative Pain Management After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Patras</source>
  <brief_summary>
    <textblock>
      The study compares three different analgesic techniques in order to determine which one
      serves as the optimal method for postoperative pain management after Total Knee Arthroplasty
      in patients suffering from Osteoarthritis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized, controlled study. Approval of the study from the University Hospital
      of Patras Ethics Committee. The Total Knee Arthroplasty procedure is performed always from
      the same team of Orthopedic surgeons who follow the same technique in each patient for the
      arthroplasty and the placement of the intraarticular catheter as well. The same team of
      Anesthesiologists (two Anesthesiologists) performs always the same technique for each
      analgesic method and is responsible for the patients' perioperative condition concerning
      anesthesia and analgesia.

      Preoperatively, one hour prior to the surgery, all patients receive preemptive multimodal
      analgesia in the following way; 40mg Parecoxib (iv), 1gr Paracetamol (iv), 150mg Pregabalin
      (po), 8mg Dexamethasone (iv) και 50mg Ranitidine (iv).

      All patients receive subarachnoid anesthesia with Ropivacaine 0.75% (7,5mg/ml) in a dosage of
      2-3ml titrated according to patient's age and height.

      Three groups

        1. Continuous epidural infusion (control group) with Ropivacaine 0.2% + clonidine 150μg.

        2. Continuous femoral nerve blockade infusion with Ropivacaine 0.2% + clonidine 150μg.

        3. Continuous intraarticular infusion with Ropivacaine 0.2% + clonidine 150μg.

      All the catheters remain for 48 hours while the infusion rate is 2ml/h + PCA with 0,5ml/15min
      and lock-out maximum dose 4/h in total volume of 150ml.

      Postoperatively all patients also receive; Parecoxib, Paracetamol, Pregabalin, and Ranitidine
      up to the third postoperative day (doses titrated).

      Rescue analgesia: Tramadol Chloride 50-100mg x 2 /24h depending on patient's age and medical
      history.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 29, 2015</start_date>
  <completion_date type="Actual">October 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative analgesia</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Pain scores, during rest and movement (active and passive) according to NRS (Numeric Rating Scale) right after the end of the surgery and 2, 4, 6, 12, 24, 36, 48, 60 and 72 hours later (postoperatively)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mobilization</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Time of mobilization (standing, walking in room, walking out of room)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LOS</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Group E- Epidural analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous epidural infusion (control group) with Ropivacaine 0.2% + clonidine 150μg for postoperative pain management right after the end of the procedure. The PCA pump is programmed with continuous infusion (Ropivacaine 0.2% + clonidine 150μg) 2ml/h and bolus dosage 0,5ml per 15min (max dosage 2ml/h). The epidural catheter is placed preoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group F- Femoral blockade</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous femoral nerve blockade infusion with Ropivacaine 0.2% + clonidine 150μg for postoperative pain management right after the end of the procedure.The PCA pump is programmed with continuous infusion (Ropivacaine 0.2% + clonidine 150μg) 2ml/h and bolus dosage 0,5ml per 15min (max dosage 2ml/h). The femoral catheter is placed preoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group I- Intraarticular infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous intraarticular infusion with Ropivacaine 0.2% + clonidine 150μg for postoperative pain management right after the end of the procedure.The PCA pump is programmed with continuous infusion (Ropivacaine 0.2% + clonidine 150μg) 2ml/h and bolus dosage 0,5ml per 15min (max dosage 2ml/h). The intraarticular catheter is placed before the closure of the incision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural analgesia - Group E</intervention_name>
    <description>Postoperative analgesia with continuous epidural infusion (control group) with Ropivacaine 0.2% + clonidine 150μg with PCA pump (2ml/h and bolus dosage 0,5ml per 15min)</description>
    <arm_group_label>Group E- Epidural analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Femoral blockade - Group F</intervention_name>
    <description>Postoperative analgesia with continuous femoral nerve blockade infusion with Ropivacaine 0.2% + clonidine 150μg with PCA pump (2ml/h and bolus dosage 0,5ml per 15min) .</description>
    <arm_group_label>Group F- Femoral blockade</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraarticular infusion - Group I</intervention_name>
    <description>Postoperative analgesia with continuous intraarticular infusion with Ropivacaine 0.2% + clonidine 150μg with PCA pump (2ml/h and bolus dosage 0,5ml per 15min)</description>
    <arm_group_label>Group I- Intraarticular infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients scheduled for unilateral total knee arthroplasty (TKA) to treat knee
             osteoarthritis (OA)

          2. Fully conversant in the Greek language

          3. Written informed consent to participate in the trial

        Exclusion Criteria:

          1. Age less than 50 years and greater than 85 years.

          2. ASA score &gt;III

          3. Pregnancy

          4. Subarachnoid anesthesia failure

          5. Hypersensitivity/ allergy to certain agent used

          6. Participation in other research/ study

          7. Severe mental disease (schizophrenia, major depression, severe bipolar disorder,
             substance abuse)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fotini Fligou, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Patras, Department of Anesthesiology and Critical Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Patras</name>
      <address>
        <city>Pátra</city>
        <state>Achaia</state>
        <zip>26500</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Patras</investigator_affiliation>
    <investigator_full_name>Georgios Karpetas</investigator_full_name>
    <investigator_title>Anesthesiologist MD</investigator_title>
  </responsible_party>
  <keyword>epidural analgesia</keyword>
  <keyword>intra-articular infusion analgesia;</keyword>
  <keyword>femoral nerve block</keyword>
  <keyword>total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

